393 related articles for article (PubMed ID: 28828688)
21. Comparison of East and West Survival Nomograms in Turkish Gastric Cancer Patients Who Underwent Radical Surgery.
Akgül Ö; Ocak S; Gündoğdu SB; Yalaza M; Güldoğan CE; Tez M
Scand J Surg; 2018 Dec; 107(4):308-314. PubMed ID: 29637843
[TBL] [Abstract][Full Text] [Related]
22. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
[TBL] [Abstract][Full Text] [Related]
23. Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Pietrantonio F; Barretta F; Fanotto V; Park SH; Morano F; Fucà G; Niger M; Prisciandaro M; Silvestris N; Bergamo F; Fornaro L; Bordonaro R; Rimassa L; Santini D; Tomasello G; Antonuzzo L; Noventa S; Avallone A; Leone F; Faloppi L; Di Donato S; de Braud F; Lee J; De Vita F; Di Bartolomeo M; Miceli R; Aprile G
Oncology; 2018; 95(6):344-352. PubMed ID: 30130791
[TBL] [Abstract][Full Text] [Related]
24. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
[TBL] [Abstract][Full Text] [Related]
26. External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer.
Kim JH; Kim HS; Seo WY; Nam CM; Kim KY; Jeung HC; Lai JF; Chung HC; Noh SH; Rha SY
Ann Oncol; 2012 Feb; 23(2):361-7. PubMed ID: 21566150
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer.
Bando E; Ji X; Kattan MW; Seo HS; Song KY; Park CH; Bencivenga M; de Manzoni G; Terashima M
Cancer Med; 2020 Aug; 9(16):5708-5718. PubMed ID: 32588982
[TBL] [Abstract][Full Text] [Related]
28. Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.
Wang ZX; Li GX; Zhou ZW; Huang ZP; Wang F; Xu RH
Br J Surg; 2017 Aug; 104(9):1226-1234. PubMed ID: 28449182
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival.
Roberto M; Botticelli A; Strigari L; Ghidini M; Onesti CE; Ratti M; Benzoni I; Pizzo C; Falcone R; Lomiento D; Donida BM; Totaro L; Mazzuca F; Marchetti P
Med Oncol; 2018 Jun; 35(7):111. PubMed ID: 29923032
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy.
Lee CK; Asher R; Friedlander M; Gebski V; Gonzalez-Martin A; Lortholary A; Lesoin A; Kurzeder C; Largillier R; Hilpert F; Hardy-Bessard AC; Kaminsky MC; Poveda A; Pujade-Lauraine E
Eur J Cancer; 2019 Aug; 117():99-106. PubMed ID: 31279306
[TBL] [Abstract][Full Text] [Related]
31. Development and external validation of a nomogram for predicting the conditional probability of survival after D2 lymphadenectomy for gastric cancer: A multicentre study.
Chen QY; Zhong Q; Wang W; Desiderio J; Liu ZY; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Li P; Zheng CH; Zhou ZW; Parisi A; Huang CM
Eur J Surg Oncol; 2019 Oct; 45(10):1934-1942. PubMed ID: 31027946
[TBL] [Abstract][Full Text] [Related]
32. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
[TBL] [Abstract][Full Text] [Related]
33. A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.
Lee CK; Hudson M; Stockler M; Coates AS; Ackland S; Gebski V; Lord S; Friedlander M; Boyle F; Simes RJ
Breast Cancer Res Treat; 2011 Sep; 129(2):467-76. PubMed ID: 21445568
[TBL] [Abstract][Full Text] [Related]
34. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.
Dikken JL; Baser RE; Gonen M; Kattan MW; Shah MA; Verheij M; van de Velde CJ; Brennan MF; Coit DG
Ann Surg Oncol; 2013 May; 20(5):1623-30. PubMed ID: 23143591
[TBL] [Abstract][Full Text] [Related]
35. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Lordick F; Kang YK; Chung HC; Salman P; Oh SC; Bodoky G; Kurteva G; Volovat C; Moiseyenko VM; Gorbunova V; Park JO; Sawaki A; Celik I; Götte H; Melezínková H; Moehler M;
Lancet Oncol; 2013 May; 14(6):490-9. PubMed ID: 23594786
[TBL] [Abstract][Full Text] [Related]
36. Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
Iveson T; Donehower RC; Davidenko I; Tjulandin S; Deptala A; Harrison M; Nirni S; Lakshmaiah K; Thomas A; Jiang Y; Zhu M; Tang R; Anderson A; Dubey S; Oliner KS; Loh E
Lancet Oncol; 2014 Aug; 15(9):1007-18. PubMed ID: 24965569
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
38. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Wilke H; Muro K; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov O; Kim TY; Cunningham D; Rougier P; Komatsu Y; Ajani J; Emig M; Carlesi R; Ferry D; Chandrawansa K; Schwartz JD; Ohtsu A;
Lancet Oncol; 2014 Oct; 15(11):1224-35. PubMed ID: 25240821
[TBL] [Abstract][Full Text] [Related]
39. Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer.
Eom BW; Joo J; Park B; Jo MJ; Choi SH; Cho SJ; Ryu KW; Kim YW; Kook MC
PLoS One; 2016; 11(8):e0159424. PubMed ID: 27482895
[TBL] [Abstract][Full Text] [Related]
40. Development and External Validation of a Simplified Nomogram Predicting Individual Survival After R0 Resection for Gastric Cancer: An International, Multicenter Study.
Zheng ZF; Lu J; Wang W; Desiderio J; Li P; Xie JW; Wang JB; Lin JX; Parisi A; Zhou ZW; Huang CM; Zheng CH
Ann Surg Oncol; 2018 Aug; 25(8):2383-2390. PubMed ID: 29881929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
